|
ZNF184 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.26856336335868E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.78299999606691E-09 |
| Normal-vs-Stage2 |
3.5964000000277E-07 |
| Normal-vs-Stage3 |
1.75249814660106E-11 |
| Normal-vs-Stage4 |
1.60690016848264E-10 |
| Stage1-vs-Stage2 |
3.771800E-01 |
| Stage1-vs-Stage3 |
6.263600E-02 |
| Stage1-vs-Stage4 |
2.149900E-02 |
| Stage2-vs-Stage3 |
6.558800E-01 |
| Stage2-vs-Stage4 |
4.205200E-01 |
| Stage3-vs-Stage4 |
6.244400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.15919554142397E-11 |
| Normal-vs-AfricanAmerican |
8.017600E-04 |
| Normal-vs-Asian |
4.45010000005297E-06 |
| Caucasian-vs-AfricanAmerican |
4.786200E-01 |
| Caucasian-vs-Asian |
6.447600E-01 |
| AfricanAmerican-vs-Asian |
7.443600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.96270000252241E-10 |
| Normal-vs-Female |
3.76060294016156E-11 |
| Male-vs-Female |
7.344400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.89430002187174E-09 |
| Normal-vs-Age(41-60Yrs) |
1.85350002013251E-09 |
| Normal-vs-Age(61-80Yrs) |
5.35804733914347E-12 |
| Normal-vs-Age(81-100Yrs) |
1.396490E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.141200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.712000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.238000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.411550E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.450600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.253600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.680000E-02 |
| Classical-VS-Follicular |
1.160670E-03 |
| Classical-VS-Other |
9.458200E-01 |
| Classical-VS-Normal |
3.16449999537838E-09 |
| Tall-VS-Follicular |
7.864000E-01 |
| Tall-VS-Other |
3.815000E-01 |
| Tall-VS-Normal |
1.67750000001909E-07 |
| Follicular-VS-Other |
3.726600E-01 |
| Follicular-VS-Normal |
1.89099957914607E-10 |
| Other-VS-Normal |
3.493500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.35149718877892E-11 |
| Normal-vs-N1 |
5.86680004577289E-09 |
| N0-vs-N1 |
4.453400E-01 |
|
|
